| Literature DB >> 35119485 |
Evelien J Vandercappellen1,2,3, Annemarie Koster3,4, Hans H C M Savelberg5,6, Simone J P M Eussen2,7, Pieter C Dagnelie1,2, Nicolaas C Schaper1,2,3, Miranda T Schram1,2,8,9, Carla J H van der Kallen1,2, Marleen M J van Greevenbroek1,2, Anke Wesselius6,10, Casper G Schalkwijk1,2, Abraham A Kroon1,2,9, Ronald M A Henry1,2,9, Coen D A Stehouwer11,12.
Abstract
AIMS/HYPOTHESIS: Biomarkers of endothelial dysfunction and low-grade inflammation are important in the pathogenesis of CVD and can potentially be modified by physical activity and sedentary behaviour. Effects of physical activity on biomarkers of endothelial dysfunction may be especially prominent in type 2 diabetes.Entities:
Keywords: Cohort study; Diabetes mellitus type 2; Endothelial dysfunction; Low-grade inflammation; Physical activity; Sedentary behaviour
Mesh:
Substances:
Year: 2022 PMID: 35119485 PMCID: PMC8960649 DOI: 10.1007/s00125-022-05651-3
Source DB: PubMed Journal: Diabetologia ISSN: 0012-186X Impact factor: 10.122
Descriptive characteristics of the study population according to physical activity pattern
| Physical activity pattern ( | ||||
|---|---|---|---|---|
| Characteristic | Total population ( | Insufficiently active ( | Weekend warrior ( | Regularly active ( |
| Age (years) | 61.0 (55.0–66.0) | 64.0 (59.0–70.0) | 63.0 (56.0–67.0) | 60.0 (54.0–66.0) |
| Sex (% male) | 51.5 | 76.3 | 57.3 | 44.6 |
| Education level (%) | ||||
| Low | 33.5 | 50.9 | 33.0 | 31.1 |
| Medium | 28.1 | 28.9 | 24.3 | 28.6 |
| High | 38.4 | 20.2 | 42.7 | 40.4 |
| Smoking status (%) | ||||
| Current | 12.5 | 24.9 | 10.1 | 10.3 |
| Former | 52.2 | 53.2 | 52.4 | 52.0 |
| Never | 35.3 | 22.0 | 37.4 | 37.7 |
| Alcohol consumption (%) | ||||
| None | 17.6 | 28.9 | 14.0 | 16.9 |
| Low | 57.0 | 54.9 | 56.7 | 57.3 |
| High | 25.4 | 16.2 | 29.4 | 25.8 |
| Mobility limitations (%) | ||||
| Yes | 20.3 | 46.8 | 17.8 | 17.4 |
| No | 79.7 | 53.2 | 82.2 | 82.6 |
| BMI (kg/m2) | 27.02 (4.54) | 30.11 (5.51) | 26.82 (4.09) | 26.42 (4.11) |
| History of CVD (%) | 16.6 | 30.1 | 16.4 | 15.0 |
| Diabetes status (%) | ||||
| Normal | 55.5 | 23.1 | 55.7 | 61.6 |
| Impaired | 15.1 | 10.4 | 16.8 | 14.8 |
| Type 2 diabetes | 28.3 | 64.7 | 26.7 | 22.4 |
| Other type of diabetes | 1.1 | 1.7 | 0.8 | 1.2 |
| Antihypertensive medication use (%) | 41.4 | 69.4 | 42.7 | 37.8 |
| Lipid-modifying medication use (%) | 37.7 | 64.2 | 37.9 | 32.9 |
| Glucose-lowering medication use (%) | 23.7 | 58.4 | 21.7 | 18.4 |
| Total cholesterol/HDL-cholesterol ratio | 3.38 (2.76–4.19) | 3.64 (3.00–4.60) | 3.45 (2.82–4.29) | 3.28 (2.70–4.06) |
| Triacylglycerol (mmol/l) | 1.22 (0.89–1.72) | 1.54 (1.12–2.14) | 1.25 (0.90–1.75) | 1.16 (0.86–1.61) |
| Dutch healthy diet index | 83.73 (14.67) | 78.19 (14.80) | 84.39 (13.63) | 85.08 (14.81) |
| Valid days ( | 7.0 (6.00–7.00) | 7.00 (6.00–7.00) | 7.0 (6.00–7.00) | 7.0 (6.00–7.00) |
| Sedentary time (h/day) | 9.42 (1.67) | 10.96 (1.51) | 9.66 (1.44) | 9.09 (1.55) |
| Total physical activity (h/day) | 1.96 (1.49–2.44) | 1.01 (0.81–1.21) | 1.85 (1.50–2.25) | 2.09 (1.68–2.55) |
| Light intensity physical activity (h/day) | 5.41 (1.52) | 4.12 (1.39) | 5.07 (1.30) | 5.69 (1.43) |
| Moderate-to-vigorous intensity physical activity (h/day) | 0.85 (0.58–1.15) | 0.27 (0.19–0.31) | 0.84 (0.64–1.10) | 0.94 (0.68–1.22) |
| Vigorous intensity physical activity (h/day) | 0.09 (0.04–0.19) | 0.02 (0.01–0.03) | 0.09 (0.05–0.18) | 0.10 (0.06–0.21) |
| Sedentary breaks ( | 37.45 (8.58) | 33.17 (8.21) | 35.50 (7.63) | 38.51 (8.25) |
| Prolonged sedentary bouts ( | 4.86 (3.71–5.86) | 6.29 (5.17–7.17) | 5.29 (4.33–6.14) | 4.46 (3.50–5.50) |
| sICAM-1 (ng/ml) | 355.62 (98.26) | 402.95 (144.46) | 353.75 (94.21) | 348.68 (85.17) |
| sVCAM-1 (ng/ml) | 428.50 (100.61) | 471.35 (135.04) | 432.68 (99.96) | 421.59 (91.75) |
| sE-selectin (ng/ml) | 117.81 (66.46) | 154.91 (112.77) | 114.12 (58.05) | 112.39 (59.95) |
| von Willebrand factor (%) | 132.20 (47.84) | 154.03 (52.48) | 134.60 (51.34) | 128.32 (44.64) |
| Plasma hs-CRP (mg/l) | 1.22 (0.61–2.72) | 1.99 (1.01–4.04) | 1.21 (0.64–2.84) | 1.12 (0.57–2.45) |
| Plasma SAA (μg/ml) | 3.36 (2.09–5.45) | 3.48 (2.10–6.89) | 3.30 (2.14–5.31) | 3.36 (2.04–5.36) |
| Plasma IL-6 (pg/ml) | 0.58 (0.39–0.90) | 0.89 (0.65–1.42) | 0.57 (0.42–0.87) | 0.55 (0.37–0.84) |
| Plasma IL-8 (pg/ml) | 4.11 (3.25–5.29) | 4.83 (3.89–6.42) | 4.23 (3.34–5.27) | 3.97 (3.19–5.13) |
| Plasma TNF-α (pg/ml) | 2.20 (1.89–2.56) | 2.50 (2.19–3.00) | 2.18 (1.86–2.55) | 2.16 (1.87–2.51) |
Values are means (SD) or median (Q1–Q3), unless stated otherwise
Associations of physical activity and sedentary behaviour with biomarkers of endothelial dysfunction score and low-grade inflammation score
| Physical activity level | Biomarkers of endothelial dysfunction | Low-grade inflammation | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 4a | Model 4b | Model 1 | Model 2 | Model 3 | Model 4a | Model 4b | |
| Total physical activity (h/day) | −0.18 (−0.22, −0.14)*** | −0.17 (−0.21, −0.13)*** | −0.11 (−0.15, −0.07)*** | – | −0.04 (−0.07, −0.01)* | −0.22 (−0.26, −0.18)*** | −0.20 (−0.24, −0.16)*** | −0.11 (−0.15, −0.08)*** | – | −0.06 (−0.09, −0.03)*** |
| Light intensity physical activity (h/day) | −0.10 (−0.14, −0.06)*** | −0.10 (−0.14, −0.06)*** | −0.05 (−0.09, −0.02)** | −0.04 (−0.08, 0.001) | −0.01 (−0.04, 0.02) | −0.14 (−0.18, −0.10)*** | −0.13 (−0.17, −0.09)*** | −0.07(−0.11, −0.04)*** | −0.05 (−0.09, −0.02)** | −0.04 (−0.07, −0.01)** |
| Moderate-to-vigorous intensity physical activity (h/day) | −0.16 (−0.20, −0.13)*** | −0.15 (−0.19, −0.11)*** | −0.09 (−0.13, −0.05)*** | −0.08 (−0.12, −0.04)** | −0.02 (−0.06, 0.01) | −0.22 (−0.26, −0.18)*** | −0.19 (−0.23, −0.15)*** | −0.11 (−0.15, −0.07)*** | −0.09 (−0.13, −0.05)*** | −0.06 (−0.10, −0.03)*** |
| Vigorous intensity physical activity (h/day) | −0.10 (−0.14, −0.06)*** | −0.09 (−0.13, −0.05)*** | −0.04 (−0.08, −0.004)* | –0.03 (−0.07, 0.01) | −0.004 (−0.04, 0.03) | −0.15 (−0.19, −0.11)*** | −0.13 (−0.17, −0.09)*** | −0.07 (−0.10, −0.03)*** | −0.06 (−0.09, −0.02)** | −0.04 (−0.07, −0.01)** |
| Sedentary time (h/day) | 0.13 (0.09, 0.17)*** | 0.13 (0.09, 0.17)*** | 0.08 (0.04, 0.12)*** | 0.06 (0.02, 0.10)** | 0.03 (−0.001, 0.07) | 0.16 (0.12, 0.20)*** | 0.15 (0.11, 0.19)*** | 0.08 (0.05, 0.12)*** | 0.05 (0.01, 0.09)* | 0.04 (0.01, 0.07)* |
| Sedentary breaks ( | −0.08 (−0.12, −0.04)*** | −0.08 (−0.12, −0.04)*** | −0.04 (−0.08, −0.002)* | −0.03 (−0.07, 0.01) | −0.01 (−0.04, 0.02) | −0.11 (−0.15, −0.07)*** | −0.10 (−0.14, −0.07)*** | −0.05 (−0.09, −0.02)** | −0.04 (−0.08, −0.004)* | −0.03 (−0.06, −0.002)* |
| Prolonged sedentary bouts ( | 0.11 (0.07, 0.15)*** | 0.12 (0.08, 0.16)*** | 0.06 (0.02, 0.10)** | 0.04 (−0.003, 0.08) | 0.02 (−0.02, 0.05) | 0.15 (0.11, 0.19)*** | 0.15 (0.11, 0.19)*** | 0.08 (0.04, 0.11)*** | 0.05 (0.01, 0.09)* | 0.05 (0.01, 0.08)** |
Regression coefficients (β) represents the increase/decrease in biomarkers of endothelial dysfunction/low-grade inflammation for every SD physical activity/sedentary behaviour
1 SD total physical activity is equivalent to 0.69 h/day; 1 SD light intensity physical activity is equivalent to 1.52 h/day; 1 SD moderate-to-vigorous intensity physical activity is equivalent to 0.45 h/day; 1 SD vigorous intensity physical activity is equivalent to 0.17 h/day; 1 SD sedentary time is equivalent to 1.67 h/day; 1 SD sedentary breaks is equivalent to 8.58 breaks/day; 1 SD prolonged sedentary bouts is equivalent to 1.57 bouts/day
Model 1 was adjusted for age, sex and glucose metabolism status; model 2 was additionally adjusted for smoking, Dutch healthy diet index and level of education; model 3 was additionally adjusted for history of CVD, BMI, mobility limitation (yes/no), triacylglycerol, total cholesterol/HDL-cholesterol ratio, use of lipid-modifying medication, use of antihypertensive medication and office systolic BP
For the sedentary behaviour and light intensity physical activity, model 4a was additionally adjusted for moderate-to-vigorous intensity physical activity; for moderate-to-vigorous intensity physical activity and vigorous intensity physical activity, model 4a was additionally adjusted for sedentary time; model 4b was additionally adjusted for low-grade inflammation (in case of biomarkers of endothelial dysfunction) and biomarkers of endothelial dysfunction (in case of low-grade inflammation)
*p<0.05, **p<0.01, ***p<0.001
Associations of physical activity pattern and CV and biomarkers of endothelial dysfunction score and low-grade inflammation score
| Physical activity pattern | Biomarkers of endothelial dysfunction | Low-grade inflammation | ||||
|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | |
| Insufficiently active | Ref | Ref | Ref | Ref | Ref | Ref |
| Weekend warrior | −0.45 (−0.61, −0.28)*** | −0.41 (−0.58, −0.24)*** | −0.28 (−0.44, −0.11)** | −0.48 (−0.64, −0.31)*** | −0.39 (−0.56, −0.23)*** | −0.22 (−0.38, −0.07)** |
| Regularly active | −0.51 (−0.66, −0.35)*** | −0.47 (−0.63, −0.31)*** | −0.32 (−0.47, −0.16)*** | −0.54 (−0.69, −0.39)*** | −0.46 (−0.61, −0.31)*** | −0.26 (−0.41, −0.11)*** |
| CV | 0.08 (0.05, 0.11)*** | 0.07 (0.04, 0.10)*** | 0.04 (0.01, 0.07)* | 0.11 (0.08, 0.14)*** | 0.09 (0.06, 0.12)*** | 0.05 (0.02, 0.08)** |
Regression results are presented as unstandardised coefficients (β), with 95% CIs
Model 1 was adjusted for age, sex and glucose metabolism status; model 2 was additionally adjusted for smoking, Dutch healthy diet index and level of education; model 3 was additionally adjusted for history of CVD, BMI, office systolic BP, mobility limitation (yes/no), triacylglycerol, total cholesterol/HDL-cholesterol ratio, use of lipid-modifying medication and use of antihypertensive medication
*p<0.05, **p<0.01, ***p<0.001
Associations of physical activity and sedentary time with biomarkers of endothelial dysfunction, stratified by glucose metabolism status
| Physical activity level | Biomarkers of endothelial dysfunction | ||
|---|---|---|---|
| Model 1 | Model 2 | Model 3 | |
| Total physical activity | |||
| Normal glucose metabolism | −0.12 (−0.17, −0.06)*** | −0.11 (−0.17, −0.06)*** | −0.06 (−0.12, −0.01)* |
| Prediabetes | −0.20 (−0.30, −0.10)*** | −0.21 (−0.31, −0.10)*** | −0.16 (−0.26, −0.05)** |
| T2D | −0.27 (−0.34, −0.19)*** | −0.25 (−0.32, −0.17)*** | −0.14 (−0.22, −0.06)*** |
| Light intensity physical activity | |||
| Normal glucose metabolism | −0.02 (−0.08, 0.03) | −0.02 (−0.08, 0.03) | 0.02 (−0.04, 0.07) |
| Prediabetes | −0.15 (−0.26, −0.04)** | −0.16 (−0.27, −0.05)** | −0.17 (−0.27, −0.06)** |
| T2D | −0.17 (−0.25, −0.10)*** | −0.17 (−0.25, −0.10)*** | −0.10 (−0.18, −0.03)** |
| Moderate-to-vigorous intensity physical activity | |||
| Normal glucose metabolism | −0.13 (−0.18, −0.07)*** | −0.12 (−0.17, −0.07)*** | −0.08 (−0.13, −0.02)** |
| Prediabetes | −0.17 (−0.27, −0.07)** | −0.16 (−0.26, −0.06)** | −0.11 (−0.21, −0.001)* |
| T2D | −0.24 (−0.31, −0.16)*** | −0.21 (−0.28, −0.13)*** | −0.10 (−0.18, −0.02)* |
| Vigorous intensity physical activity | |||
| Normal glucose metabolism | −0.11 (−0.16, −0.05)*** | −0.10 (−0.16, −0.05)*** | −0.06 (−0.11, −0.002)* |
| Prediabetes | −0.10 (−0.20, 0.01) | −0.09 (−0.19, 0.02) | −0.03 (−0.13, 0.08) |
| T2D | −0.15 (−0.22, −0.07)*** | −0.12 (−0.20, −0.05)** | −0.05 (−0.13, 0.02) |
| Sedentary time | |||
| Normal glucose metabolism | 0.06 (0.001, 0.10)* | 0.06 (0.003, 0.12)* | 0.02 (−0.04, 0.07) |
| Prediabetes | 0.20 (0.10, 0.31)*** | 0.22 (0.11, 0.33)*** | 0.21 (0.10, 0.31)*** |
| T2D | 0.18 (0.11, 0.26)*** | 0.18 (0.10, 0.25)*** | 0.10 (0.02, 0.17)* |
Regression coefficients (β) represents the increase/decrease in biomarkers of endothelial dysfunction for every SD physical activity/sedentary behaviour
1 SD total physical activity is equivalent to 0.67 h/day, 1 SD light intensity physical activity is equivalent to 1.48 h/day, 1 SD moderate-to-vigorous intensity physical activity is equivalent to 0.43 h/day, 1 SD vigorous intensity physical activity is equivalent to 0.16 h/day, 1 SD sedentary time is equivalent to 1.60 h/day
Model 1 was adjusted for age and sex; model 2 was additionally adjusted for smoking, Dutch healthy diet index and level of education; model 3 was additionally adjusted for history of CVD, BMI, office systolic BP, mobility limitation (yes/no), triacylglycerol, total cholesterol/HDL-cholesterol ratio, use of lipid-modifying medication and use of antihypertensive medication
*p<0.05, **p<0.01, ***p<0.001
T2D, type 2 diabetes